Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Neurofibromatosis 2

imatinib mesylate has been researched along with Neurofibromatosis 2 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Souza, P; Lim, S1
Ammoun, S; Hanemann, CO; Manley, P; Schmid, MC; Triner, J1
Akgün, E; Avsar, T; Bayri, Y; Kılıç, T; Şeker, A; Yener, U1
DesJardins, A; Reardon, DA; Rich, JN; Sathornsumetee, S; Vredenburgh, JJ1

Other Studies

4 other study(ies) available for imatinib mesylate and Neurofibromatosis 2

ArticleYear
Imatinib in neurofibromatosis type 2.
    BMJ case reports, 2013, Jul-08, Volume: 2013

    Topics: Adult; Benzamides; Humans; Imatinib Mesylate; Male; Neurofibromatosis 2; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2013
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.
    Neuro-oncology, 2011, Volume: 13, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Imatinib Mesylate; Immunoblotting; MAP Kinase Signaling System; Neurilemmoma; Neurofibromatosis 2; Neurofibromin 2; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction

2011
Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
    Journal of neurosurgery, 2012, Volume: 117, Issue:4

    Topics: Animals; Antineoplastic Agents; Benzamides; Brain; Cornea; Cranial Nerve Neoplasms; Glioblastoma; Humans; Imatinib Mesylate; Male; Neovascularization, Pathologic; Neurofibromatosis 2; Neuroma, Acoustic; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Treatment Outcome; Xenograft Model Antitumor Assays

2012
Neurofibromatosis type 2.
    Neurology, 2007, Mar-27, Volume: 68, Issue:13

    Topics: Antineoplastic Agents; Benzamides; Cochlear Nerve; Female; Functional Laterality; Hearing Loss, Sensorineural; Humans; Hydroxyurea; Imatinib Mesylate; Magnetic Resonance Imaging; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Piperazines; Pyrimidines; Treatment Outcome; Vestibular Nerve

2007